Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform

Posted on by

RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine Investment will help fund pre-market approval for use in spine, trauma and orthopaedics Biocomposites, CEO, Michael Harris will join Renovos Biologics Board of Directors KEELE, England, July…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.